Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Third International Stroke Trial (IST-3) of thrombolysis for acute ischaemic stroke
2004-000238-36Phase 3Completed
- Sponsor
- University of Edinburgh
- Start
- Aug 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of tissue-plasminogen activator in ischemic stroke (2 arms), sponsored by University of Edinburgh. Primary endpoint: Functional independence at 6 months. Started Aug 2007; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2004-000238-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000238-36.